Press release
Leading Element Driving Change in the Oral Transmucosal Drugs Market in 2025: Parkinson's Disease Driving Growth In Oral Transmucosal Drug Market Driver
Oral Transmucosal Drugs Market
The rising incidence of Parkinson's disease is expected to boost the oral transmucosal drug market. Parkinson's disease, a progressive neurological disorder, is becoming more prevalent due to an aging population, environmental factors, and better diagnostic techniques. Oral transmucosal drugs offer fast absorption and relief, enhancing treatment adherence and reducing motor complications. According to the Parkinson's Foundation, the number of Parkinson's patients in the U.S. is expected to rise from 1 million in 2022 to 1.2 million by 2030, propelling the growth of the oral transmucosal drug market.
Get Your Oral Transmucosal Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/oral-transmucosal-drugs-global-market-report
What growth opportunities are expected to drive the oral transmucosal drugs market's CAGR through 2034?
The oral transmucosal drugs market has grown significantly, increasing from $39.7 billion in 2024 to $43.53 billion in 2025 at a CAGR of 9.6%. Growth has been fueled by advances in diagnostics, aging demographics, environmental factors, genetic predispositions, faster drug absorption for rapid relief, and improved patient adherence.
The oral transmucosal drugs market is projected to grow significantly, reaching $62.03 billion in 2029 with a CAGR of 9.3%. Growth will be propelled by advances in personalized medicine, novel drug delivery research, an aging population, rising awareness of oral health, and increased demand for non-invasive treatments. Emerging trends include novel formulations, personalized medicine approaches, telehealth expansion, digital health integration, and pharmaceutical technology innovations.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15627&type=smp
What are the emerging trends shaping the future of the oral transmucosal drugs market?
Companies in the oral transmucosal drug market are developing sublingual vitamin sprays to enhance drug delivery effectiveness, improve patient convenience, and optimize therapeutic outcomes. A sublingual vitamin spray delivers vitamins directly into the bloodstream through the mucous membranes under the tongue, bypassing the digestive system. For example, in October 2022, Vestige Marketing, an India-based wellness company, launched Absorvit, a sublingual vitamin spray. Absorvit offers swift absorption and rapid results, providing enhanced delivery of essential vitamins, including B12, C, D, and multivitamins, ensuring better nutrition for overall wellness.
Which growth-oriented segments of the oral transmucosal drugs market are leading the industry's development?
The oral transmucosal drugs market covered in this report is segmented -
1) By Product Type: Tablets, Films, Liquid And Spray, Other Product Types
2) By Indication: Opioid Dependence, Nausea And Vomiting, erec*tile Dysfunction, Neurological Disorders, Other Indications
3) By Route Of Administration: Sublingual Mucosa, Buccal Mucosa, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Tablets: Buccal Tablets, Sublingual Tablets, Effervescent Tablets
2) By Films: Buccal Films, Sublingual Films, Mucoadhesive Films
3) By Liquid And Spray: Sublingual Liquid Solutions, Oral Sprays (Pain Relief, Sleep Aids), Mucosal Gels
4) By Other Product Types: Lozenges, Pastilles, Chewing Gums
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15627
What regions are leading the charge in the oral transmucosal drugs market?
North America was the largest region in the oral transmucosal drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral transmucosal drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the oral transmucosal drugs market?
Major companies operating in the oral transmucosal drugs market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi-Aventis LLC, AstraZeneca PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Eli Lilly & Company Ltd., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., Actavis Pharma Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Ltd., Endo Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Mallinckrodt Pharmaceuticals Plc, Glenmark Pharmaceuticals Limited, Jubilant Life Sciences Limited, Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Wockhardt Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15627&type=smp
What Is Covered In The Oral Transmucosal Drugs Global Market Report?
•Market Size Forecast: Examine the oral transmucosal drugs market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the oral transmucosal drugs market for a structured understanding.
•Key Players Overview: Analyze major players in the oral transmucosal drugs market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the oral transmucosal drugs market.
•Segment Contributions: Evaluate how different segments drive overall growth in the oral transmucosal drugs market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the oral transmucosal drugs market.
•Industry Challenges: Identify potential risks and obstacles affecting the oral transmucosal drugs market.
•Competitive Landscape: Review strategic developments in the oral transmucosal drugs market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Element Driving Change in the Oral Transmucosal Drugs Market in 2025: Parkinson's Disease Driving Growth In Oral Transmucosal Drug Market Driver here
News-ID: 3928108 • Views: …
More Releases from The Business Research Company
New Growth Trends Accelerating Expansion In The Fluoropolymer Films Market
The fluoropolymer films market is on track for significant expansion in the coming years, driven by advancements and increasing applications across multiple industries. As demand grows for durable, high-performance materials, this sector presents promising opportunities for manufacturers and end-users alike. Let's explore the market's anticipated size, key players, evolving trends, and primary segments shaping its future.
Projected Market Size and Growth Trends in the Fluoropolymer Films Market
The fluoropolymer films…
Strategic Drivers And Emerging Shifts Influencing The Flock Adhesive Market Land …
The flock adhesive market is positioned for notable expansion over the coming years as industries increasingly seek advanced bonding solutions. With growing environmental considerations and evolving application needs, this market is set to attract more attention and investments, promising significant growth through 2030.
Projected Growth and Market Size of the Flock Adhesive Industry
The flock adhesive market is anticipated to reach a valuation of $3.89 billion by 2030, expanding at…
Growth Trends, Segment Breakdown, And Competitor Strategies Shaping The Flexible …
The flexible plastic packaging industry is positioned for substantial expansion over the coming years, driven by evolving consumer preferences and technological advancements. This sector is witnessing increasing investment in sustainability and innovation, which are shaping its growth trajectory. Below is a detailed exploration of the market's size, key players, emerging trends, and segmentation.
Projected Growth and Market Size for Flexible Plastic Packaging
The flexible plastic packaging market is forecasted to…
Flexible Pet Care Packaging Market Structure, Emerging Trends, And Leading Playe …
The flexible pet care packaging sector is set to experience remarkable expansion over the coming years, driven by evolving consumer preferences and industry innovation. This market's transformation reflects growing environmental awareness and changing demands for pet food packaging that ensures product quality and convenience. Let's explore the market's valuation, key players, future trends, and detailed segments to better understand its trajectory.
Forecasted Market Size and Growth Trajectory for Flexible Pet Care…
More Releases for Pharma
Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten …
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed…
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
